Section 0400-20-07-.14 - NOTIFICATIONS(1) A licensee shall provide the Division, no later than 30 days after the date that the licensee allows an individual to work under the provisions of subparagraph (1)(b) of Rule 0400-20-07-.13 as an authorized user, authorized medical physicist, ophthalmic physicist, or authorized nuclear pharmacist the following: (a) A copy of the board certification and, as appropriate, verification of completion of: 1. Training for the authorized medical physicist under Rule 0400-20-07-.24;2. Any additional case experience required in item (1)(b)1(ii)(VI) of Rule 0400-20-07-.47 for an authorized user under Rule 0400-20-07-.44; or3. Device-specific training in subparagraph (1)(c) of Rule 0400-20-07-.80 for the authorized user under Rule 0400-20-07-.63; or(b) A copy of the U.S, Nuclear Regulatory Commission or Agreement State license, the permit issued by a U.S. Nuclear Regulatory Commission master material licensee, the permit issued by a U.S. Nuclear Regulatory Commission or Agreement State licensee of broad scope, the permit issued by a U.S. Nuclear Regulatory Commission master material license broad scope permittee, or documentation that only accelerator-produced radioactive materials, discrete sources of radium-226, or both, were used for medical use or in the practice of nuclear pharmacy at a Government agency or Federally recognized Indian Tribe before November 30, 2007, or at all other locations of use before August 8, 2009, or an earlier date as noticed by the U.S. Nuclear Regulatory Commission for each individual whom the licensee permits to work under the provisions of this rule.(2) A licensee shall notify the Division no later than 30 days after: (a) An authorized user, an authorized nuclear pharmacist, a radiation safety officer, an associate radiation safety officer, an authorized medical physicist, or ophthalmic physicist permanently discontinues performance of duties under the license or has a name change;(b) The licensee allows an individual qualified to be a radiation safety officer under Rule 0400-20-07-.23 and 0400-20-07-.27 to function as a temporary radiation safety officer and to perform the functions of a radiation safety officer in accordance with paragraph (3) of Rule 0400-20-07-.17;(c) The licensee's mailing address changes;(d) The licensee's name changes, but the name change does not constitute a transfer of control of the license as described in paragraph (2) of Rule 0400-20-10-.16; or(e) The licensee has added to or changed the areas of use identified in the application or on the license where radioactive material is used under either Rule 0400-20-07-.38 or 0400-20-07-.40 if the change does not include addition or relocation of either an area where PET radionuclides are produced or a PET radioactive drug delivery line from the PET radionuclide or PET radioactive drug production area; or(f) The licensee obtains a sealed source for use in manual brachytherapy from a different manufacturer or with a different model number than authorized by its license for which it did not require a license amendment as provided in Rule 0400-20-07-.13. The notification must include the manufacturer and model number of the sealed source, the isotope, and the quantity per sealed source.(3) The licensee shall send the documents required in this rule to the Division at the address listed in Rule 0400-20-04-.07.Tenn. Comp. R. & Regs. 0400-20-07-.14
Original rule filed February 22, 2012; effective May 22, 2012. Amendments filed December 4, 2023; effective 3/3/2024.Authority: T.C.A. §§ 4-5-201, et seq.; 68-202-101, et seq.; and 68-202-201, et seq.